Neoplasms Clinical Trials in New Brunswick, New Jersey

3 studies are recruiting for neoplasms in New Brunswick, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

    The purpose of this study is to characterize safety and to determine the Recommended Phase 2 Dose (RP2D[s]) and optimal dosing schedule(s) of JNJ-88549968 in part 1 (Dose Escalation); to characterize the safety of JNJ- 88549968 at RP2D(s) in part 2 (Cohort Expansion). For U.S. sites: the purpose of…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
    Locations
    44 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT06150157 on ClinicalTrials.gov

  2. Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

    This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least o…

    Stage
    Phase 2
    Ages
    Any age
    Site
    Local Institution - 01053, New Brunswick, New Jersey
    Locations
    222 in total
    Run by
    Celgene

    See if you can join NCT03435796 on ClinicalTrials.gov

  3. A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

    The goal of this study is to assess the safety, tolerability, clinical activity and pharmacokinetics of Risvutatug rezetecan (Ris-Rez), also known as GSK5764227. The study will also see how the levels of Ris-Rez will change over time at different dose amounts when administered alone and in combinat…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    GSK Investigational Site, New Brunswick, New Jersey
    Locations
    67 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT06551142 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.